[
    [
        {
            "time": "",
            "original_text": "万泰生物：公司传统的冻干水痘减毒活疫苗处于III临床试验中，新型冻干水痘减毒活疫苗（VZV-7D）处于II期临床试验中",
            "features": {
                "keywords": [
                    "万泰生物",
                    "冻干水痘减毒活疫苗",
                    "III临床试验",
                    "新型疫苗",
                    "VZV-7D",
                    "II期临床试验"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗研发"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "万泰生物：公司的20价肺炎多糖蛋白结合疫苗主要面向2岁及以下婴幼儿",
            "features": {
                "keywords": [
                    "万泰生物",
                    "20价肺炎多糖蛋白结合疫苗",
                    "婴幼儿市场"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗研发"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        }
    ]
]